Face atopic dermatitis resistant to dupilumab: a case series of three patients successfully treated with upadacitinib

J Eur Acad Dermatol Venereol. 2022 Feb;36(2):e150-e152. doi: 10.1111/jdv.17705. Epub 2021 Sep 30.

Authors

G Licata¹, A Gambardella¹, V Tancredi¹, G Calabrese¹, A De Rosa¹, R Alfano², G Argenziano¹

Affiliations

¹ Dermatology Unit, Department of Mentals and Physical Health and Preventive medicine, University of Campania Luigi Vanvitelli, Naples, Italy.
² Department of Anesthesiology, Surgery and Emergency, University of Campania Luigi Vanvitelli, Naples, Italy.

PMID: 34553800
DOI: 10.1111/jdv.17705

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal, Humanized
Dermatitis, Atopic* / drug therapy
Female
Heterocyclic Compounds, 3-Ring
Humans
Male
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
Heterocyclic Compounds, 3-Ring
dupilumab
upadacitinib